Cite
HARVARD Citation
Winkler, A. et al. (2021). The Interleukin‐1 Receptor–Associated Kinase 4 Inhibitor PF‐06650833 Blocks Inflammation in Preclinical Models of Rheumatic Disease and in Humans Enrolled in a Randomized Clinical Trial. Arthritis & rheumatology. 73 (12), pp. 2206-2218. [Online].